University Hospital, Linkoeping
regionostergotland.seTotal trials
118
Active
13
Phase 3
5
Total enrollment
947,709
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Saline | — | — | — | — | — | 2 | |
| Vancomycin + Tobramycin | — | — | — | — | — | 1 | |
| Chemotherapy drug | — | — | — | — | — | 2 | |
| Tinzaparin Injectable Solution | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
- 2027-12
- 2028-12
Top conditions
- Frailty5
- Osteoporosis4
- Cardiovascular Disease3
- Burns3
- Healthy Subjects3
- Rotator Cuff Tear3
- Hysterectomy2
- Vertebral Fracture2
Frequently asked questions about University Hospital, Linkoeping
- How many clinical trials does University Hospital, Linkoeping have on ClinicalTrials.gov?
- University Hospital, Linkoeping is listed as the lead sponsor on 118 clinical trials in ClinicalTrials.gov, 13 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Hospital, Linkoeping's trials are in Phase 3?
- 5 of University Hospital, Linkoeping's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does University Hospital, Linkoeping focus on?
- University Hospital, Linkoeping's most-studied conditions on ClinicalTrials.gov are Frailty, Osteoporosis, Cardiovascular Disease, Burns, Healthy Subjects.
- When are University Hospital, Linkoeping's next clinical trial readouts?
- University Hospital, Linkoeping has 3 upcoming primary-completion readouts tracked here; the soonest is “Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars”, expected around 2025-12-31.